Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Study: Most Patients Can Safely Continue Weight Loss, Diabetes Drugs Before Gynecologic Surgery First gynecologic-focused review supports newer guidance on continued use of GLP-1 medications Most patients taking popular weight loss and diabetes medications such as Ozempic and Wegovy can safely continue them before gynecologic surgery, according to a new journal article from ChristianaCare published in Obstetrics & Gynecology
It means having access to the right medication at the right dose, without the stress of pharmacy shortages or insurance denials
The study recruited 411 patients and showed that danuglipron reduced glycated hemoglobin, fasting blood glucose and body weight at week 16 compared with placebo and was well tolerated without the need for injections or fasting restrictions (Saxena et al., 2023)
Wegovy is specifically approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition
NovaGenix also offers convenient subcutaneous options
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
